|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 13th Street, NW |
Address2 | 11th Floor North |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3867-12
|
||||||||
|
6. House ID# 315600000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jesse Kerns |
Date | 1/20/2023 10:21:26 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to drug pricing reform
Public law 117-1769 Inflation Reduction Act
HR 2617 Consolidated Appropriations Act of 2023,
--issues related to cardiovascular disease,
--Issues related to FTC,
--FDA issues (Food and Drug Omnibus Reforms Act)
--Issues related to Pharmacy Benefit Manger transparency
--Issues related to clinical trial diversity
S1435 affordable prescriptions for patients act
H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act
H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
Biosimilars reimbursement issues, no specific bill
Supply Chain Issues, no specific bill
Issues related to biodefense issues, S3799 PREVENT Pandemics Act
Issues related to cardiovascular disease awareness, S. 3018/ HR 3173 Improving Seniors Timely Access to Care Act
Issues related to 340B
H.R. 5801 HELP Copays Act
Issues related to patient affordability issues, including copay cards, copay accumulators, National Benefit Payment Parameters
HR 8588 Fair Care Act, 340B hospital reporting
HR 4390 Protect 340B Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
William |
O'Brien |
|
|
|
Helen |
Rhee |
|
|
|
Jesse |
Kerns |
|
|
|
L. Nicole |
Currie |
|
|
|
Greg |
Portner |
|
|
|
Victoria |
Blatter |
|
|
|
Howard |
Moon |
|
|
|
Ruth |
Hoffman |
|
|
|
Jordan |
Layson |
|
|
|
Kim |
Love |
|
|
|
Winta |
Menghis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Public law 117-1769 Inflation Reduction Act
HR 2617 Consolidated Appropriations Act of 2023
Issues related to drug pricing reform and Medicare Part D redesign
S. 1943 and H.R. 3517, Issues related to DXA scans, osteoporosis
issues related to cardiovascular disease awareness
Issues related to ESRD
Issues related to asthma and self-administered drug list
Reimbursement for biologics/biosimilars
Issues related to discarded drugs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
L. Nicole |
Currie |
|
|
|
Greg |
Portner |
|
|
|
Helen |
Rhee |
|
|
|
Jesse |
Kerns |
|
|
|
Victoria |
Blatter |
|
|
|
William |
O'Brien |
|
|
|
Howard |
Moon |
|
|
|
Ruth |
Hoffman |
|
|
|
Jordan |
Layson |
|
|
|
Kim |
Love |
|
|
|
Winta |
Menghis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to corporate and international tax, including regarding Public Law 115-97, Tax Cuts and Jobs Act
Issues related to Puerto Rico
Issues related to OECD negotiations on the taxation of global income
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
L. Nicole |
Currie |
|
|
|
Helen |
Rhee |
|
|
|
Jordan |
Layson |
|
|
|
Victoria |
Blatter |
|
|
|
Howard |
Moon |
|
|
|
Greg |
Portner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S.1435 Affordable Prescriptions for Patients Act
H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act
H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
S 2891 Restore the America Invents Act
S. 2774 - Pride in Patent Ownership Act
S. 4704 - Patent Examination and Quality Improvement Act of 2022
S. 4417 - Patent Trial and Appeal Board Reform Act of 2022
S. 4430 - Interagency Patent Coordination and Improvement Act of 2022
FTC related issues
Issues related to the Patent Act
Issues related to march-in/Bayh Dole, WTO/TRIPS waiver, no specific bill
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Helen |
Rhee |
|
|
|
Greg |
Portner |
|
|
|
L. Nicole |
Currie |
|
|
|
William |
O'Brien |
|
|
|
Victoria |
Blatter |
|
|
|
Howard |
Moon |
|
|
|
Jesse |
Kerns |
|
|
|
Jordan |
Layson |
|
|
|
Kim |
Love |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |